Key Questions To Ask When Entering A Pharma Partnership

By Jody Staggs

Rising interest rates have created challenges for life sciences companies seeking funding. The cost of equity or venture debt has increased dramatically since 2021, and for some biotech companies is not available at any price. For these companies, non-dilutive funding via a strategic partner can be a compelling alternative, although it carries risks.

Before entering a partnership, executives need to ask themselves and their prospective partners’ key questions in the following five areas: